Skip to Content

G 367 (Topiramate Extended-Release 25 mg)

Pill with imprint G 367 is Beige / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Glenmark Pharmaceuticals Inc..

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 367

Topiramate Extended-Release

Imprint
G 367
Strength
25 mg
Color
Beige / Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc.
National Drug Code (NDC)
68462-0372

Get help with Imprint Code FAQs.

Related Images for "G 367"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.